Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130,255,320
-
Total 13F shares
-
34,628,854
-
Share change
-
-501,962
-
Total reported value
-
$74,450,307
-
Price per share
-
$2.15
-
Number of holders
-
52
-
Value change
-
-$3,009,412
-
Number of buys
-
17
-
Number of sells
-
38
Institutional Holders of Ovid Therapeutics Inc. - COMMON STOCK (OVID) as of Q2 2022
As of 30 Jun 2022 Ovid Therapeutics Inc. - COMMON STOCK (OVID) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,628,854 shares of stock of the company.
Largest 10 holders included BVF INC/IL, EcoR1 Capital, LLC, Stonepine Capital Management, LLC, Rubric Capital Management LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Inc., and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This table shows 52 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.